Latest Biotech Startup Funding Rounds
Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.
- Rounds
- 473 All time
- Disclosed funding
- $19.6B 400 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| CD Building AI models to accelerate pre-clinical drug discovery | $400M | Series CSeries C+ | Biotech | United States | Investors | |
| DF Drug FarmCompany profile Drug Farm develops treatments for ROSAH syndrome, heart and kidney diseases, hepatitis B, and metabolic diseases Drug Farm develops treatments for ROSAH syndrome, heart and kidney diseases, hepatitis B, and metabolic diseases | $55M | Series DSeries C+ | Biotech | China | Investors | |
| KA Develops microalgal ingredients using dark fermentation. | Undisclosed | Series B | Biotech | United States | Investors | |
| AT Allotera TherapeuticsCompany profile Clinical-stage developer of off-the-shelf CAR-T cell therapies, including Sofi-cel for aggressive T-cell cancers. Clinical-stage developer of off-the-shelf CAR-T cell therapies, including Sofi-cel for aggressive T-cell cancers. | $35M | Series C extension and venture debtSeries C+ | Biotech | United States | Investors | |
| LC Leo Cancer CareCompany profile Develops cancer-care systems for treating patients in an upright position. Develops cancer-care systems for treating patients in an upright position. | $65M | Series DSeries C+ | Biotech, Healthtech | United States | Investors | |
| RD Respiro DiagnosticsCompany profile Develops breath-based diagnostic platform for lung cancer and respiratory diseases Develops breath-based diagnostic platform for lung cancer and respiratory diseases | £1M | Pre-SeedPre-seed | Biotech, Healthtech | United Kingdom | Investors | |
| A AardaiaCompany profile Crop breeding that turns wild plants into agricultural varieties using genomics and large-scale screening. Crop breeding that turns wild plants into agricultural varieties using genomics and large-scale screening. | €5M | Seed | Biotech, Agritech | Netherlands | Investors | |
| HT Healome TherapeuticsCompany profile Develops proprietary eye-drop matrix technology for ocular surface diseases Develops proprietary eye-drop matrix technology for ocular surface diseases | £2M | Seed | Biotech | United Kingdom | Investors | |
| CT Cyllene TherapeuticsCompany profile Develops DNA medicines for severe neurogenic bladder conditions and other neurological diseases Develops DNA medicines for severe neurogenic bladder conditions and other neurological diseases | €33M | Series CSeries C+ | Biotech | France | Investors | |
| C CurifyLabsCompany profile CurifyLabs develops software and GMP-manufactured excipients for preparing personalized medicines. CurifyLabs develops software and GMP-manufactured excipients for preparing personalized medicines. | $14M | Series A | Biotech, Healthtech | Finland | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
22rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.